Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY (MRK)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Business Summary
Logo Merck and Company
Discovers, develops and markets human and animal health products

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.

It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.

The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as vaccines, which it sells to veterinarians, distributors, and animal producers.

The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients.

The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Number of employees : 69 000 people.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Pharmaceutical35,15189%35,39088.5% +0.68%
Other Segment3,8629.8%4,27210.7% +10.62%
Other794.002%460.001.2% -42.07%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States18,47846.8%17,42443.6% -5.7%
Europe, Middle East and Africa10,95327.7%11,47828.7% +4.79%
Asia Pacific3,9189.9%4,33710.8% +10.69%
Japan2,8467.2%3,1227.8% +9.7%
Latin America2,1555.5%2,3395.9% +8.54%
Other1,4573.7%1,4223.6% -2.4%
Managers
NameAgeSinceTitle
Kenneth Frazier631992Chairman, President & Chief Executive Officer
Robert M. Davis, MBA512014CFO & Executive Vice President-Global Services
Thomas Henry Glocer592007Independent Director
Rochelle B. Lazarus, MBA702004Independent Director
Leslie Brun652008Lead Independent Director
Carlos Eduardo Represas de Almeida722009Independent Director
Patricia Fiorello Russo651995Independent Director
Craig B. Thompson, MD652008Independent Director
Wendell Weeks582004Independent Director
Peter C. Wendell, MBA672003Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 3,566,586,887 2,657,595,191 74.5% 907,061,576 25.4% 74.5%
Shareholders
NameEquities%
The Vanguard Group, Inc. 197,937,446 7.44%
BlackRock Fund Advisors 122,463,625 4.60%
SSgA Funds Management, Inc. 109,400,038 4.11%
Capital Research & Management Co. (World Investors) 104,997,673 3.95%
Wellington Management Co. LLP 74,299,418 2.79%
T. Rowe Price Associates, Inc. 42,618,526 1.60%
Northern Trust Investments, Inc. 32,610,158 1.23%
Geode Capital Management LLC 30,700,659 1.15%
Norges Bank Investment Management 28,441,659 1.07%
JPMorgan Investment Management, Inc. 27,612,846 1.04%
Holdings
NameEquities%Valuation
Kalvista Pharmaceuticals Inc (KALV) 1,070,5898.51%18,307,072 USD
Menlo Therapeutics Inc (MNLO) 1,243,1685.41%9,547,530 USD
OpGen Inc (OPGN) 216,5363.49%415,749 USD
Sutro Biopharma, Inc. 2,056,843426.7%21 USD
Markets and indexes
- NYSE
- Main Market
- DJIA / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  MRK:US
- Reuters Code :  MRK.N
- Datastream Code :  U:MRK
Company contact information
Merck and Company
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey
États-Unis (les)

Phone : +1 908 423 1000
Fax : +1 908 735 1253
Internet : http://www.merck.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MERCK AND COMPANY26.36%189 092
JOHNSON & JOHNSON2.26%383 312
PFIZER21.65%258 285
NOVARTIS-0.63%216 108
ROCHE HOLDING LTD.-4.60%211 501
AMGEN17.94%132 756
ABBOTT LABORATORIES20.99%121 136
ELI LILLY AND COMPANY25.89%114 197
SANOFI3.69%109 540
BRISTOL-MYERS SQUIBB COMPANY1.58%101 584
GLAXOSMITHKLINE15.80%99 260
ASTRAZENECA10.72%92 763
NOVO NORDISK A/S-9.87%89 924
BAYER-25.23%83 828
ALLERGAN PLC16.95%64 939
CELGENE CORPORATION-15.94%61 699
SHIRE17.15%55 437
CHUGAI PHARMACEUTICAL CO LTD21.66%34 889
ASTELLAS PHARMA INC35.00%34 414
TAKEDA PHARMACEUTICAL CO LTD-27.49%33 259
JIANGSU HENGRUI MEDICINE CO LTD14.62%31 793
Connections : Merck and Company
SARR Group LLC
BlueVoyant LLC
The Conference Board, Inc.
Rush University Medical Center
National Institute of Genomic Medicine
Gambro AB
Columbia Business School
The International Business Council
NXT Capital LLC
The Cleveland Clinic Foundation
Pharmaceutical Research & Manufacturers of America
Verto Analytics, Inc.
AdvaMedDx
Advertising Women of New York
Verto Analytics Oy
The American Law Institute
K2 Intelligence, Inc.
Bombardier Mexico SA de CV
Atlantic Council
Schweizerische Rückversicherungs-Gesellschaft AG
Supreme Court of the United States
Blueteam Investor LLC
New York State Bar Association
The Society of Memorial Sloan-Kettering Cancer Center
Yale University
Women's Forum, Inc.
Forum Mondial de L'Economie
Direct Marketing Association, Inc.
The Library of Congress (District of Columbia)
The Committee of 200
European Business Leaders' Convention
American Bar Association
Angelic Ventures LP
Council on Foreign Relations, Inc.
President's Export Council
G100 Cos.
National Academy of Sciences
Weill Cornell Medical College
American Society for Clinical Investigation
Fundacion Mexicana Para La Salud AC
Cornerstone Christian Academy
Latin American Business Council
Arconic Defense, Inc.
KKR Management LLC
Lehigh University
The Pennsylvania State University
Corning, Inc. Foundation
The Economic Club of New York
Exploratorium
Memorial Sloan-Kettering Cancer Center
American Academy of Arts & Sciences
Charles River Laboratories, Inc.
NewYork-Presbyterian Hospital
American Association for Cancer Research
The Partnership for New York City
Institute of Medicine
Lincoln Center for the Performing Arts, Inc.
American Association of Physicists In Medicine
World Wildlife Fund, Inc.
CMI Marketing, Inc.
The Corning Museum of Glass
Committee Encouraging Corporate Philanthropy
ARTstor, Inc.
United States Defense Business Board
Sierra Ventures, Inc.
Official Publications
08/06Report 
08/02Report 
08/01Report 
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem